Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR201305000551876Completed
Open-label trial of amodiaquine, sulfadoxine + pyrimethamine and artemether + lumefantrine in malaria (2 arms), sponsored by Cheikh Anta Diop University. Primary endpoint: Incidence rate of malaria attacks. Started Sep 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR201305000551876.